论文信息 - Phase II study of the PD1-inhibitor pembrolizumab for the treatment of relapsed or refractory mature t-cell lymphoma. - 字舞流文

Phase II study of the PD1-inhibitor pembrolizumab for the treatment of relapsed or refractory mature t-cell lymphoma.

Sonali M. Smith | R. Fisher | Y. Oki | E. Ross | R. Alpaugh | J. Ruan | K. Campbell | S. Barta | H. Fung | J. Zain | Yibin Yang | N. Khan | C. Tan